Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

122.11
Delayed Data
As of 3:59pm ET
 -2.98 / -2.38%
Today’s Change
96.18
Today|||52-Week Range
145.42
-0.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues737.4M786.3M831.0M850.0M
 
 
 
 
 
Cost of Goods Sold42.9M52.5M47.3M50.0M
 
 
 
 
 
Depreciation And Amortization97.8M100.7M100.7M99.0M
 
 
 
 
 
 
Operating ExpensesGross Income596.8M633.2M683.0M701.0M
 
 
 
 
 
General Expenses411.1M425.8M465.0M481.0M
 
 
 
 
 
Research And Development179.3M195.7M206.0M219.0M
 
 
 
 
 
Total Operating Expenses551.8M578.9M613.0M630.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income185.6M207.4M218.0M220.0M
 
 
 
 
 
Extraordinary Charge-6.6M-40.9M-90.0M-37.0M
 
 
 
 
 
Interest Expense On Debt23.8M24.8M25.0M23.0M
 
 
 
 
 
Other Expenses13.0M12.4M-1.0M30.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income170.0M158.1M104.0M194.0M
 
 
 
 
 
Income Taxes-55.0M-63.8M-11.0M-24.0M
 
 
 
 
 
Net Income114.9M94.3M93.0M170.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS224.1M224.2M225.0M224.0M
 
 
 
 
 
Shares To Calculate EPS Diluted225.8M226.1M226.0M226.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.51$0.42$0.41$0.75
 
 
 
 
 
EPS Diluted$0.51$0.42$0.41$0.75